Receptor interactions of the position 4 side chains of angiotensin II analogues: importance of aromatic ring quadrupole. 1994

G J Moore, and R C Ganter, and J M Matsoukas, and J Hondrelis, and G Agelis, and K Barlos, and S Wilkinson, and J Sandall, and P Fowler
Department of Pharmacology and Therapeutics, University of Calgary, Alberta, Canada.

A triad of interacting groups (TyrOH-His-O2C) in angiotensin II (ANG II) has been postulated to create the tyrosinate anion pharmacophore (tyanophore) responsible for receptor activation/triggering (Biochim. Biophys. Acta 1991, 1065, 21). In the present study we investigated the effects on bioactivity of substituting the Tyr4 residue in [Sar1]ANG II with other anionic or electronegative amino acids, and with a number of aromatic amino acids lacking a hydroxyl group. [Sar1 Nva(delta-OH)4]ANG II, [Sar1 Nva(delta-OCH3)4]ANG II, [Sar1 Met4]ANG II, [Sar1 Gln4]ANG II, [Sar1 Glu4]ANG II and [Sar1 DL-Alg]ANG II had agonist activities in the rat isolated uterus assay of 4, 3, 19, 10, < 0.1 and < 0.1%, respectively, of that of ANG II. [Sar1 Nal4]ANG II, [Sar1 Pal4]ANG II, [Sar1 DL-Phg(4'-F)4]ANG II, [Sar1 Phe(4'-F)4]ANG II, [Sar1 Phe(F5)4]ANG II and [Sar1 His4]ANG II had agonist activities of 4.5, 7, < 0.1, 0.2, 1 and 0.6%, respectively. All peptides investigated were devoid of measurable antagonist activity except [Sar1 Phe(4'-F)4ANG II (pA2 = 7.7). These findings illustrate that anionic or electronegative aliphatic side chains replacing tyrosinate at position 4 can partially activate the angiotensin receptor. For ANG II analogues containing an aromatic amino acid other than Tyr at position 4, ligand binding and agonist activity are not dependent on the electronegativity or dipole moment of the aromatic ring, or on the ability of the 4' ring substituent to accept a proton.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011945 Receptors, Angiotensin Cell surface proteins that bind ANGIOTENSINS and trigger intracellular changes influencing the behavior of cells. Angiotensin Receptor,Angiotensin Receptors,Angiotensin II Receptor,Angiotensin III Receptor,Receptor, Angiotensin II,Receptor, Angiotensin III,Receptor, Angiotensin
D002627 Chemistry, Physical The study of CHEMICAL PHENOMENA and processes in terms of the underlying PHYSICAL PHENOMENA and processes. Physical Chemistry,Chemistries, Physical,Physical Chemistries
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino

Related Publications

G J Moore, and R C Ganter, and J M Matsoukas, and J Hondrelis, and G Agelis, and K Barlos, and S Wilkinson, and J Sandall, and P Fowler
September 1979, Journal of medicinal chemistry,
G J Moore, and R C Ganter, and J M Matsoukas, and J Hondrelis, and G Agelis, and K Barlos, and S Wilkinson, and J Sandall, and P Fowler
June 2000, Arzneimittel-Forschung,
G J Moore, and R C Ganter, and J M Matsoukas, and J Hondrelis, and G Agelis, and K Barlos, and S Wilkinson, and J Sandall, and P Fowler
November 1985, International journal of peptide and protein research,
G J Moore, and R C Ganter, and J M Matsoukas, and J Hondrelis, and G Agelis, and K Barlos, and S Wilkinson, and J Sandall, and P Fowler
May 1999, Biophysical journal,
G J Moore, and R C Ganter, and J M Matsoukas, and J Hondrelis, and G Agelis, and K Barlos, and S Wilkinson, and J Sandall, and P Fowler
January 1994, Journal of molecular biology,
G J Moore, and R C Ganter, and J M Matsoukas, and J Hondrelis, and G Agelis, and K Barlos, and S Wilkinson, and J Sandall, and P Fowler
September 1979, Journal of medicinal chemistry,
G J Moore, and R C Ganter, and J M Matsoukas, and J Hondrelis, and G Agelis, and K Barlos, and S Wilkinson, and J Sandall, and P Fowler
November 1981, Journal of medicinal chemistry,
G J Moore, and R C Ganter, and J M Matsoukas, and J Hondrelis, and G Agelis, and K Barlos, and S Wilkinson, and J Sandall, and P Fowler
July 2019, Journal of the American Chemical Society,
G J Moore, and R C Ganter, and J M Matsoukas, and J Hondrelis, and G Agelis, and K Barlos, and S Wilkinson, and J Sandall, and P Fowler
November 1991, Biopolymers,
G J Moore, and R C Ganter, and J M Matsoukas, and J Hondrelis, and G Agelis, and K Barlos, and S Wilkinson, and J Sandall, and P Fowler
May 2009, Kidney international,
Copied contents to your clipboard!